Incyte

Prezzo Delle Azioni
102.96
Cambio Giornaliero
2.04 2.02%
Mensile
1.15%
Annuale
36.81%
Q1 Previsione
96.99




Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Amgen USD 5.91B 2.31B 2025-09
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Incyte USD 581.52M 358.87M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novartis USD 5.88B 290M 2025-09
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Incyte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.